(NASDAQ: FLGT) Fulgent Genetics's forecast annual revenue growth rate of 10.03% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.68%.
Fulgent Genetics's revenue in 2025 is $283,470,000.On average, 2 Wall Street analysts forecast FLGT's revenue for 2025 to be $9,572,237,172, with the lowest FLGT revenue forecast at $9,557,130,740, and the highest FLGT revenue forecast at $9,587,343,605. On average, 2 Wall Street analysts forecast FLGT's revenue for 2026 to be $10,586,526,209, with the lowest FLGT revenue forecast at $10,515,926,759, and the highest FLGT revenue forecast at $10,657,125,659.
In 2027, FLGT is forecast to generate $11,579,542,922 in revenue, with the lowest revenue forecast at $11,579,542,922 and the highest revenue forecast at $11,579,542,922.